Shoreline Biosciences, a gene editing and cell therapy biotech, has let go of staffers dedicated to a cell therapy project that’s working with Gilead’s Kite … ...
IGM Biosciences announced plans to stay afloat by focusing its resources on a clinical-stage autoimmune asset. Now it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback